Immunogenicity and safety following a homologous booster dose of a SARSCoV2 recombinant spike protein vaccine with MatrixMTM adjuvant NVXCoV2373 versus a primary series in people living with and without HIV1 infection in South Africa A randomized cro
| dc.article.end-page | 12 | en |
| dc.article.start-page | 1 | en |
| dc.citation.doi | 10.1080/21645515.2024.2425147 | en |
| dc.contributor.author | V Shinde | en |
| dc.contributor.author | Anthonet Koen | en |
| dc.contributor.author | Z Hoosain | en |
| dc.contributor.author | M Archary | en |
| dc.contributor.author | Q Bhorat | en |
| dc.contributor.author | Lee Fairlie | en |
| dc.contributor.author | Aylin Oommen Jose | en |
| dc.contributor.author | Dishiki Kalonji | en |
| dc.contributor.author | E et al | en |
| dc.contributor.author | Shabir Madhi | en |
| dc.date.accessioned | 2025-04-13T06:51:10Z | |
| dc.department | WITS REPRODUCTIVE HEALTH AND HIV INSTITUTE | en |
| dc.faculty | FACULTY OF HEALTH SCIENCES | en |
| dc.identifier.citation | WOS | en |
| dc.identifier.issn | 2164-5515 | en |
| dc.identifier.uri | https://hdl.handle.net/10539/44736 | |
| dc.journal.title | Immunogenicity and safety following a homologous booster dose of a SARSCoV2 recombinant spike protein vaccine with MatrixMTM adjuvant NVXCoV2373 versus a primary series in people living with and without HIV1 infection in South Africa A randomized cro | en |
| dc.journal.volume | 20 | en |
| dc.title | Immunogenicity and safety following a homologous booster dose of a SARSCoV2 recombinant spike protein vaccine with MatrixMTM adjuvant NVXCoV2373 versus a primary series in people living with and without HIV1 infection in South Africa A randomized cro | en |
| dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Journal Article.pdf
- Size:
- 1.79 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client